Redlight Guide

Brain health / cognition

Transcranial red light therapy for brain health and cognition

Emerging human evidence for transcranial photobiomodulation in cognition and mood, with clear separation from consumer panel claims.

Study count

Cited source set includes 10 records, including 7 source(s) imported from the PlatinumLED news source inventory.

Evidence grade

low

Panel relevance

not-panel-replicable

Bottom line

Brain-health claims need the most restraint: cite tPBM separately, avoid treating consumer panels as brain devices, and avoid mental-health treatment claims.

Consensus: tPBM has an intriguing positive signal for cognition, but the evidence is emerging, device-specific, and not equivalent to whole-body panels.

What the studies found

  • A 2023 review identified 35 human studies and reported that 29 showed positive cognitive findings.
  • A 2019 healthy-adult meta-analysis found improved cognition-related outcomes but noted possible publication bias.
  • A depression-focused review described preliminary evidence and biological rationale, while calling for large RCTs.
  • Platinum-sourced additions broaden the citation map; imported records need full-text review before converting them into stronger efficacy claims.

Dosage and timing

Wavelengths630, 635, 810, 1060, 1068 nm
IrradianceA common clinical-population protocol in one review used 20-25 mW/cm2.
FluenceA common clinical-population protocol in one review used 1-10 J/cm2.
Session timeVaried by study.
FrequencyVaried by population and device.
DurationVaried by population and device.
TimingNo general time-of-day consensus.
Treatment areaScalp/transcranial targets.
Device typesTranscranial PBM helmets, arrays, or targeted devices.
NotesScalp penetration, placement, power, and safety screening are central.
  • The most common cited clinical-population protocol used 810 nm, 20-25 mW/cm2, and 1-10 J/cm2.
  • There is no consensus that a consumer panel at a distance delivers a meaningful or safe transcranial dose.
  • Mental-health and neurological uses should be described as experimental unless tied to clinician-supervised protocols.
  • Imported records with missing protocol fields are not used as calculator presets.

Caveats

  • Avoid claims that red light panels treat depression, dementia, traumatic brain injury, or neurological disease.
  • Eye safety, heat, scalp dosing, and contraindications need more explicit review before any practical guide.
  • Publication bias and trial quality are live concerns.
  • Some added citations are indirect, mechanistic, animal, or specialist-device studies and should not be generalized to home panels.

Cited peer-reviewed sources

systematic-review 35 included studies Evidence: low; direction: positive Panel relevance: not-panel-replicable Wavelengths: 630, 635, 810, 1060, 1068 nm Dose/timing: 10 J/cm2 / Varied by population and study / Varied by population and study Area: Scalp / transcranial targets Device: Transcranial photobiomodulation devices Source

Lee TL, Ding Z, Chan AS. Ageing Research Reviews. 2023.

A systematic review found many positive cognitive studies, but only about half of clinical trials were randomized and sham-controlled.

Source

meta-analysis 9 included studies Evidence: low; direction: positive Panel relevance: not-panel-replicable Wavelengths: Not reported Dose/timing: Varied by study / Varied by study Area: Transcranial targets Device: Transcranial photobiomodulation devices Source

Salehpour F, Majdi A, Pazhuhi M, et al. Photobiomodulation, Photomedicine, and Laser Surgery. 2019.

A meta-analysis of healthy adults reported improved cognition-related outcomes, but with publication-bias concerns.

Source

systematic-review Study count not extracted Evidence: very-low; direction: unclear Panel relevance: not-panel-replicable Wavelengths: Not reported Dose/timing: Experimental; not settled / Experimental; not settled Area: Transcranial targets Device: Transcranial red/NIR photobiomodulation Source

Cassano P, Petrie SR, Hamblin MR, et al. Neurophotonics. 2016.

A review described preliminary evidence and biological rationale for tPBM in depression, while emphasizing the need for large RCTs.

Source

animal-or-in-vitro Study count not extracted Evidence: indirect; direction: unclear Panel relevance: not-panel-replicable Wavelengths: Not reported Dose/timing: Not extracted from Platinum intake metadata / Not extracted from Platinum intake metadata Area: Not extracted Device: Peer-reviewed source; device/protocol requires full-text review Source

Naeser MA, Hamblin MR. Photomed Laser Surg. 2011.

Imported from the PlatinumLED news source inventory as a peer-reviewed citation. This first-pass record preserves source metadata and needs full-text protocol extraction before it should be used for consumer dosing guidance.

Source

other Study count not extracted Evidence: very-low; direction: mixed Panel relevance: partially-replicable Wavelengths: Not reported Dose/timing: Not extracted from Platinum intake metadata / Not extracted from Platinum intake metadata Area: Not extracted Device: Peer-reviewed source; device/protocol requires full-text review Source

Nizamutdinov D, Qi X, Berman MH, Dougal G, Dayawansa S, Wu E, Yi SS, Stevens AB, Huang JH. Aging Dis. 2021.

Imported from the PlatinumLED news source inventory as a peer-reviewed citation. This first-pass record preserves source metadata and needs full-text protocol extraction before it should be used for consumer dosing guidance.

Source

other Study count not extracted Evidence: very-low; direction: mixed Panel relevance: partially-replicable Wavelengths: Not reported Dose/timing: Not extracted from Platinum intake metadata / Not extracted from Platinum intake metadata Area: Not extracted Device: Peer-reviewed source; device/protocol requires full-text review Source

Hamblin MR. J Neurosci Res. 2018.

Imported from the PlatinumLED news source inventory as a peer-reviewed citation. This first-pass record preserves source metadata and needs full-text protocol extraction before it should be used for consumer dosing guidance.

Source

uncontrolled-trial Study count not extracted Evidence: very-low; direction: mixed Panel relevance: partially-replicable Wavelengths: Not reported Dose/timing: Not extracted from Platinum intake metadata / Not extracted from Platinum intake metadata Area: Not extracted Device: Peer-reviewed source; device/protocol requires full-text review Source

Naeser MA, Zafonte R, Krengel MH, Martin PI, Frazier J, Hamblin MR, Knight JA, Meehan WP, Baker EH. J Neurotrauma. 2014.

Imported from the PlatinumLED news source inventory as a peer-reviewed citation. This first-pass record preserves source metadata and needs full-text protocol extraction before it should be used for consumer dosing guidance.

Source

systematic-review Study count not extracted Evidence: low; direction: mixed Panel relevance: partially-replicable Wavelengths: Not reported Dose/timing: Not extracted from Platinum intake metadata / Not extracted from Platinum intake metadata Area: Not extracted Device: Peer-reviewed source; device/protocol requires full-text review Source

Caldieraro MA, Cassano P. J Affect Disord. 2019.

Imported from the PlatinumLED news source inventory as a peer-reviewed citation. This first-pass record preserves source metadata and needs full-text protocol extraction before it should be used for consumer dosing guidance.

Source

randomized-controlled-trial Study count not extracted Evidence: low; direction: positive Panel relevance: partially-replicable Wavelengths: Not reported Dose/timing: Not extracted from Platinum intake metadata / Not extracted from Platinum intake metadata Area: Not extracted Device: Peer-reviewed source; device/protocol requires full-text review Source

Casalechi HL, Dumont AJL, Ferreira LAB, de Paiva PRV, Machado CDSM, de Carvalho PTC, Oliveira CS, Leal-Junior ECP. Lasers Med Sci. 2020.

Imported from the PlatinumLED news source inventory as a peer-reviewed citation. This first-pass record preserves source metadata and needs full-text protocol extraction before it should be used for consumer dosing guidance.

Source

uncontrolled-trial Study count not extracted Evidence: very-low; direction: mixed Panel relevance: partially-replicable Wavelengths: Not reported Dose/timing: Not extracted from Platinum intake metadata / Not extracted from Platinum intake metadata Area: Not extracted Device: Peer-reviewed source; device/protocol requires full-text review Source

Schiffer F, Johnston AL, Ravichandran C, Polcari A, Teicher MH, Webb RH, Hamblin MR. Behav Brain Funct. 2009.

Imported from the PlatinumLED news source inventory as a peer-reviewed citation. This first-pass record preserves source metadata and needs full-text protocol extraction before it should be used for consumer dosing guidance.

Source

Last reviewed: 2026-06-15